Faithward Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$469K Buy
5,113
+514
+11% +$45K 0.06% 213
2026
Q1
$392K Buy
4,599
+416
+10% +$37.1K 0.06% 205
2025
Q4
$331K Sell
4,183
-132
-3% -$10.3K 0.05% 245
2025
Q3
$345K Buy
4,315
+94
+2% +$8.02K 0.05% 230
2025
Q2
$384K Buy
4,221
+1
+0% +$91 0.06% 195
2025
Q1
$395K Hold
4,220
0.07% 179
2024
Q4
$384K Sell
4,220
-41
-1% -$3.91K 0.07% 180
2024
Q3
$442K Buy
4,261
+13
+0.3% +$1.32K 0.08% 180
2024
Q2
$412K Buy
4,248
+38
+0.9% +$3.5K 0.07% 178
2024
Q1
$379K Buy
+4,210
New +$357K 0.07% 183
2023
Q2
Sell
-3,046
Closed -$249K 278
2023
Q1
$249K Buy
+3,046
New +$226K 0.06% 164

Other funds holding CL

Faithward Advisors's CL Position: Q2 2026 in Review

Faithward Advisors increased its Colgate-Palmolive (CL) stake by 11% in Q2 2026, buying an estimated $45K and bringing the position to 5,113 shares worth $469K. The position accounts for 0.06% of the portfolio, ranked #213.

Faithward Advisors first reported a position in CL in Q1 2023 and has held it in 11 quarters since. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Faithward Advisors held 5,113 shares of Colgate-Palmolive worth $469K as of Q2 2026.
  • Faithward Advisors bought 514 Colgate-Palmolive shares in Q2 2026, an estimated $45K.
  • Colgate-Palmolive made up 0.06% of Faithward Advisors's portfolio in Q2 2026, its #213 holding.
  • Faithward Advisors first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 11 quarters since.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.